SU‐FF‐J‐71: A Prototype Fiducial Marker Composed of Gold Nanoparticles and Bone Cement for Proton Therapy of Prostate Cancers

Y. K. Lim, J. W. Kwak, D. W. Kim, D. H. Shin, Myonggeun Yoon, S. H. Ahn, S. A. Park, D. H. Lee, S. B. Lee, S. Y. Park, D. Y. Kim

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Purpose: The feasibility of using mixtures of gold nanoparticles and bone cement as fiducial markers was examined to solve the problems of conventional gold markers for proton therapy of prostate cancers. Method and Materials: To investigate the feasibility of replacement of a conventional gold fiducial marker by a mixture of gold nanoparticles and bone cement, two kinds of interactions were examined: one is the interactions of them with kV and MV X‐rays, and the other is their interactions with a therapeutic proton beam. We qualitatively and quantitatively compared radiographic visibility, CT artifacts, and dose reduction of each material. Results: The gold nanoparticle‐bone cement mixtures could extremely reduce the distortions of depth‐dose distribution behind them as well as the artifacts around them, in comparison with the conventional gold fiducial. The gold nanoparticle‐bone cement mixtures could also be easily distinguished from high density organs, such as pelvic bone in kV and MV X‐rays, while it was nearly transparent to a proton beam. Conclusion: We fabricated prototype fiducial markers composed of gold nanoparticle and bone cement, and examined their excellent potential, such as good radiographic visibility, low distortion of depth‐dose distribution, and few CT artifacts, for serving as fiducial markers for proton therapy of prostate cancer.

Original languageEnglish
Pages (from-to)2492
Number of pages1
JournalMedical Physics
Volume36
Issue number6
DOIs
Publication statusPublished - 2009
Externally publishedYes

Fingerprint

Fiducial Markers
Proton Therapy
Bone Cements
Gold
Nanoparticles
Prostatic Neoplasms
Artifacts
Protons
X-Rays
Pelvic Bones

ASJC Scopus subject areas

  • Biophysics
  • Radiology Nuclear Medicine and imaging

Cite this

SU‐FF‐J‐71 : A Prototype Fiducial Marker Composed of Gold Nanoparticles and Bone Cement for Proton Therapy of Prostate Cancers. / Lim, Y. K.; Kwak, J. W.; Kim, D. W.; Shin, D. H.; Yoon, Myonggeun; Ahn, S. H.; Park, S. A.; Lee, D. H.; Lee, S. B.; Park, S. Y.; Kim, D. Y.

In: Medical Physics, Vol. 36, No. 6, 2009, p. 2492.

Research output: Contribution to journalArticle

Lim, YK, Kwak, JW, Kim, DW, Shin, DH, Yoon, M, Ahn, SH, Park, SA, Lee, DH, Lee, SB, Park, SY & Kim, DY 2009, 'SU‐FF‐J‐71: A Prototype Fiducial Marker Composed of Gold Nanoparticles and Bone Cement for Proton Therapy of Prostate Cancers', Medical Physics, vol. 36, no. 6, pp. 2492. https://doi.org/10.1118/1.3181363
Lim, Y. K. ; Kwak, J. W. ; Kim, D. W. ; Shin, D. H. ; Yoon, Myonggeun ; Ahn, S. H. ; Park, S. A. ; Lee, D. H. ; Lee, S. B. ; Park, S. Y. ; Kim, D. Y. / SU‐FF‐J‐71 : A Prototype Fiducial Marker Composed of Gold Nanoparticles and Bone Cement for Proton Therapy of Prostate Cancers. In: Medical Physics. 2009 ; Vol. 36, No. 6. pp. 2492.
@article{a55b2e7f298a4ca580d4abceee975a3a,
title = "SU‐FF‐J‐71: A Prototype Fiducial Marker Composed of Gold Nanoparticles and Bone Cement for Proton Therapy of Prostate Cancers",
abstract = "Purpose: The feasibility of using mixtures of gold nanoparticles and bone cement as fiducial markers was examined to solve the problems of conventional gold markers for proton therapy of prostate cancers. Method and Materials: To investigate the feasibility of replacement of a conventional gold fiducial marker by a mixture of gold nanoparticles and bone cement, two kinds of interactions were examined: one is the interactions of them with kV and MV X‐rays, and the other is their interactions with a therapeutic proton beam. We qualitatively and quantitatively compared radiographic visibility, CT artifacts, and dose reduction of each material. Results: The gold nanoparticle‐bone cement mixtures could extremely reduce the distortions of depth‐dose distribution behind them as well as the artifacts around them, in comparison with the conventional gold fiducial. The gold nanoparticle‐bone cement mixtures could also be easily distinguished from high density organs, such as pelvic bone in kV and MV X‐rays, while it was nearly transparent to a proton beam. Conclusion: We fabricated prototype fiducial markers composed of gold nanoparticle and bone cement, and examined their excellent potential, such as good radiographic visibility, low distortion of depth‐dose distribution, and few CT artifacts, for serving as fiducial markers for proton therapy of prostate cancer.",
author = "Lim, {Y. K.} and Kwak, {J. W.} and Kim, {D. W.} and Shin, {D. H.} and Myonggeun Yoon and Ahn, {S. H.} and Park, {S. A.} and Lee, {D. H.} and Lee, {S. B.} and Park, {S. Y.} and Kim, {D. Y.}",
year = "2009",
doi = "10.1118/1.3181363",
language = "English",
volume = "36",
pages = "2492",
journal = "Medical Physics",
issn = "0094-2405",
publisher = "AAPM - American Association of Physicists in Medicine",
number = "6",

}

TY - JOUR

T1 - SU‐FF‐J‐71

T2 - A Prototype Fiducial Marker Composed of Gold Nanoparticles and Bone Cement for Proton Therapy of Prostate Cancers

AU - Lim, Y. K.

AU - Kwak, J. W.

AU - Kim, D. W.

AU - Shin, D. H.

AU - Yoon, Myonggeun

AU - Ahn, S. H.

AU - Park, S. A.

AU - Lee, D. H.

AU - Lee, S. B.

AU - Park, S. Y.

AU - Kim, D. Y.

PY - 2009

Y1 - 2009

N2 - Purpose: The feasibility of using mixtures of gold nanoparticles and bone cement as fiducial markers was examined to solve the problems of conventional gold markers for proton therapy of prostate cancers. Method and Materials: To investigate the feasibility of replacement of a conventional gold fiducial marker by a mixture of gold nanoparticles and bone cement, two kinds of interactions were examined: one is the interactions of them with kV and MV X‐rays, and the other is their interactions with a therapeutic proton beam. We qualitatively and quantitatively compared radiographic visibility, CT artifacts, and dose reduction of each material. Results: The gold nanoparticle‐bone cement mixtures could extremely reduce the distortions of depth‐dose distribution behind them as well as the artifacts around them, in comparison with the conventional gold fiducial. The gold nanoparticle‐bone cement mixtures could also be easily distinguished from high density organs, such as pelvic bone in kV and MV X‐rays, while it was nearly transparent to a proton beam. Conclusion: We fabricated prototype fiducial markers composed of gold nanoparticle and bone cement, and examined their excellent potential, such as good radiographic visibility, low distortion of depth‐dose distribution, and few CT artifacts, for serving as fiducial markers for proton therapy of prostate cancer.

AB - Purpose: The feasibility of using mixtures of gold nanoparticles and bone cement as fiducial markers was examined to solve the problems of conventional gold markers for proton therapy of prostate cancers. Method and Materials: To investigate the feasibility of replacement of a conventional gold fiducial marker by a mixture of gold nanoparticles and bone cement, two kinds of interactions were examined: one is the interactions of them with kV and MV X‐rays, and the other is their interactions with a therapeutic proton beam. We qualitatively and quantitatively compared radiographic visibility, CT artifacts, and dose reduction of each material. Results: The gold nanoparticle‐bone cement mixtures could extremely reduce the distortions of depth‐dose distribution behind them as well as the artifacts around them, in comparison with the conventional gold fiducial. The gold nanoparticle‐bone cement mixtures could also be easily distinguished from high density organs, such as pelvic bone in kV and MV X‐rays, while it was nearly transparent to a proton beam. Conclusion: We fabricated prototype fiducial markers composed of gold nanoparticle and bone cement, and examined their excellent potential, such as good radiographic visibility, low distortion of depth‐dose distribution, and few CT artifacts, for serving as fiducial markers for proton therapy of prostate cancer.

UR - http://www.scopus.com/inward/record.url?scp=85024778254&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024778254&partnerID=8YFLogxK

U2 - 10.1118/1.3181363

DO - 10.1118/1.3181363

M3 - Article

AN - SCOPUS:85024778254

VL - 36

SP - 2492

JO - Medical Physics

JF - Medical Physics

SN - 0094-2405

IS - 6

ER -